Newsroom

SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc., (Nasdaq: TVTX) announced that today the U.S. Food and Drug Administration (FDA) has extended the review timeline of its supplemental New Drug Application (sNDA) for FILSPARI® (sparsentan) in focal segmental glomerulosclerosis (FSGS). The new Prescription Drug User Fee Act (PDUFA) target action date is April 13, 2026. The extension follows the recent submission of responses requested by the FDA to further characterize the clinical benefit o...

LONDON--(BUSINESS WIRE)--  Re: Bausch+Lomb Netherlands B.V. EUR 23,173,000.00 MATURING: 15-Jan-2031 ISIN: XS3102032110 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 15-Jan-2026 TO 15-Apr-2026 HAS BEEN FIXED AT 5.89 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 15-Apr-2026 WILL AMOUNT TO: EUR 203,975.88 PER EUR 13,850,000.00 DENOMINATION  ...

DUBLIN--(BUSINESS WIRE)--The "Supplier and Contract Manufacturer Management: Compliance, Qualification & Oversight (Feb 18th - Feb 19th, 2026)" training has been added to ResearchAndMarkets.com's offering. This comprehensive supplier management course is designed to enhance your skills in effectively managing supplier relationships throughout their lifecycle. From supplier identification and qualification to building strong relationships, risk management, continuous assessment, and exit pla...

SAN FRANCISCO--(BUSINESS WIRE)--Hipcamp and the Sierra Club partner to make six historic Tahoe huts and cabins easier to discover and book....

DUBLIN--(BUSINESS WIRE)--The "FDA Recalls Masterclass: Proactive Preparation and Post-Recall Compliance (Jan 21st - Jan 22nd, 2026)" training has been added to ResearchAndMarkets.com's offering. This course will teach how to establish a roadmap for conducting recalls. The knowledge you gain will sharpen your recall management decisions and strategy. You will learn how to use the FDA's health risk criteria so you can develop effective recall procedures. One critical aspect of recalls involves th...

PALO ALTO, Calif.--(BUSINESS WIRE)--Period of transformative growth across all major healthcare verticals follows its Series C, which raised $126 million at a $3.5 billion valuation....

DUBLIN--(BUSINESS WIRE)--The "Online Printing Services Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. The Online Printing Services Market is experiencing notable growth, valued at USD 20.69 billion in 2024 and projected to reach USD 34.69 billion by 2032 with a CAGR of 6.66%. This report delves into the intricate landscape of online printing services, outlining strategic drivers, stakeholder priorities, and their implications on modern operational pract...

LONDON--(BUSINESS WIRE)--  Re: Atlas Funding 2024-1 PLC GBP 4,040,000.00 MATURING: 20-Sep-2061 ISIN: XS2819820528 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Dec-2025 TO 20-Jan-2026 HAS BEEN FIXED AT 7.43 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 20-Jan-2026 WILL AMOUNT TO: GBP 8,345.63 PER GBP 1,413,631.01 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: Atlas Funding 2024-1 PLC GBP 15,390,000.00 MATURING: 20-Sep-2061 ISIN: XS2819820106 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Dec-2025 TO 20-Jan-2026 HAS BEEN FIXED AT 5.34 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 20-Jan-2026 WILL AMOUNT TO: GBP 68,669.39 PER GBP 16,183,636.70 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: ATLAS FUNDING 2023 -1 PLC GBP 2,174,000.00 MATURING: 20-Jan-2061 ISIN: XS2601814754 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Dec-2025 TO 20-Jan-2026 HAS BEEN FIXED AT 13.52 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 20-Jan-2026 WILL AMOUNT TO: GBP 24,589.15 PER GBP 2,289,000.00 DENOMINATION  ...